title: Optimal tube length for the submerged printing of ovarian cancer cells.
abstract: Ovarian cancer is the fifth most common cancer affecting US women, killing more women each year than all other gynecologic cancers combined. Treatment of ovarian cancer is challenging with an overall 5-year survival rates of only 28-46% based on the metastatic state of the disease. While overall survival has improved with modern chemotherapy, poor outcomes have persisted. One of the greatest challenges in cancer therapeutic research remains that late-stage drug development trials for drug candidates have high attrition rates, up to 70% in Phase II and 59% in Phase III trials. The development of in vitro, high-throughput, cell based assays could provide a tool to overcome the challenges associated with high attrition rates by allowing for controlled cell deposition with a defined, controlled phenotype. Submerged, three-dimensional (3D) microfluidic printing technology is uniquely capable of controlling cell deposition without sacrificing the viability of cells for cell-based assays. Here, we investigate the phenotypic effects of tube length during printing on the cells. We observe that the length of the tube has minimal effects on the viability and density of A2780 ovarian cancer cells different cell lines. This study details foundational information for developing a high-throughput cell-based assays (CBA) for screening effective cancer drug candidates.
authors.affiliation: Wasatch Microfluidics.
authors.forename: Sherry N
authors.initials: SN
authors.lastname: Davidoff
authors.forename: Kenzie L
authors.initials: KL
authors.lastname: Stallings
authors.forename: Amanda E
authors.initials: AE
authors.lastname: Brooks
authors.forename: Bruce K
authors.initials: BK
authors.lastname: Gale
authors.forename: Benjamin D
authors.initials: BD
authors.lastname: Brooks